JP2023509372A5 - - Google Patents

Info

Publication number
JP2023509372A5
JP2023509372A5 JP2022537288A JP2022537288A JP2023509372A5 JP 2023509372 A5 JP2023509372 A5 JP 2023509372A5 JP 2022537288 A JP2022537288 A JP 2022537288A JP 2022537288 A JP2022537288 A JP 2022537288A JP 2023509372 A5 JP2023509372 A5 JP 2023509372A5
Authority
JP
Japan
Prior art keywords
unsubstituted
pharmaceutically acceptable
acceptable salt
substituted
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022537288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509372A (ja
JP7657223B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/065719 external-priority patent/WO2021127250A1/en
Publication of JP2023509372A publication Critical patent/JP2023509372A/ja
Publication of JP2023509372A5 publication Critical patent/JP2023509372A5/ja
Application granted granted Critical
Publication of JP7657223B2 publication Critical patent/JP7657223B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022537288A 2019-12-19 2020-12-17 炎症性疾患および男性避妊用rarアルファ化合物 Active JP7657223B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962950473P 2019-12-19 2019-12-19
US62/950,473 2019-12-19
PCT/US2020/065719 WO2021127250A1 (en) 2019-12-19 2020-12-17 Rar-alpha compounds for inflammatory disease and male contraception

Publications (3)

Publication Number Publication Date
JP2023509372A JP2023509372A (ja) 2023-03-08
JP2023509372A5 true JP2023509372A5 (https=) 2023-12-25
JP7657223B2 JP7657223B2 (ja) 2025-04-04

Family

ID=74186909

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022537288A Active JP7657223B2 (ja) 2019-12-19 2020-12-17 炎症性疾患および男性避妊用rarアルファ化合物

Country Status (7)

Country Link
US (1) US12492177B2 (https=)
EP (1) EP4077300A1 (https=)
JP (1) JP7657223B2 (https=)
CN (1) CN115335367B (https=)
AU (1) AU2020408043A1 (https=)
CA (1) CA3165166A1 (https=)
WO (1) WO2021127250A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12492177B2 (en) 2019-12-19 2025-12-09 Orphagen Pharmaceuticals, Inc. RAR-α compounds for inflammatory disease and male contraception

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
US5877207A (en) * 1996-03-11 1999-03-02 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6521641B1 (en) * 1998-10-08 2003-02-18 Allergan, Inc. Male anti-fertility agents
AU757448B2 (en) 1998-10-08 2003-02-20 Allergan, Inc. Male anti-fertility agents
US20020193403A1 (en) 2001-05-03 2002-12-19 Allergan Sales, Inc. Methods of treating hyperlipidemia
US7105566B2 (en) * 2002-10-22 2006-09-12 Allergan, Inc. Methods of treatment during vascular procedures
DK3204357T3 (da) 2014-10-10 2022-04-04 High Force Res Limited Fluorescerende, syntetiske retinoider
WO2017201200A1 (en) 2016-05-19 2017-11-23 Orphagen Pharmaceuticals, Inc. Therapeutic compositions containing rar-alpha antagonists
DE102016123286B4 (de) 2016-12-01 2019-03-07 Deutsches Zentrum für Luft- und Raumfahrt e.V. Verfahren und Vorrichtung zur Georeferenzierung von Luftbilddaten
EP3709990A4 (en) * 2017-11-17 2021-12-01 The Regents of the University of California MANIPULATION OF THE RETIC ACID SIGNAL PATH
CN114041070B (zh) 2018-11-19 2024-03-08 棱镜传感器公司 边缘式光子计数检测器
US12492177B2 (en) 2019-12-19 2025-12-09 Orphagen Pharmaceuticals, Inc. RAR-α compounds for inflammatory disease and male contraception

Similar Documents

Publication Publication Date Title
JP2011037841A5 (https=)
JP2021523221A5 (https=)
JP2022534426A5 (https=)
JP2018533593A5 (https=)
JP2021523200A5 (https=)
JP2010511721A5 (https=)
JP2021514400A5 (https=)
JP2015503621A5 (https=)
JP2014500870A5 (https=)
JP2019524883A5 (https=)
JP2014501766A5 (https=)
JP2016534148A5 (https=)
JP2018536634A5 (https=)
JP2016540742A5 (https=)
JP2006524222A5 (https=)
JP2017538689A5 (https=)
JP2005535586A5 (https=)
JP2011509949A5 (https=)
JP2005534669A5 (https=)
JP2015536947A5 (https=)
JP2009535307A5 (https=)
JP2010502730A5 (https=)
JP2007502295A5 (https=)
RU2013138372A (ru) Производные азетидина, применяемые для лечения метаболических и воспалительных заболеваний
JP2021046404A5 (https=)